Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Metabolic Brain Disease
Metadata
Title
Introduction
Author
Vicente Felipo
Publication date
01-12-2005
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Metabolic Brain Disease / Issue 4/2005
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-005-7903-7

Other articles of this Issue 4/2005

Metabolic Brain Disease 4/2005 Go to the issue

OriginalPaper

Chronic Systemic Endotoxin Exposure: An Animal Model in Experimental Hepatic Encephalopathy

OriginalPaper

Molecular Mechanisms of the Alterations in NMDA Receptor-Dependent Long-Term Potentiation in Hyperammonemia

OriginalPaper

Endogenous Neuroprotectants in Ammonia Toxicity in the Central Nervous System: Facts and Hypotheses

OriginalPaper

Role of Phosphate-Activated Glutaminase in the Pathogenesis of Hepatic Encephalopathy

OriginalPaper

Neurophysiological Investigation of Hepatic Encephalopathy

OriginalPaper

Role of Endogenous Benzodiazepine Ligands and Their GABA-A-Associated Receptors in Hepatic Encephalopathy